Uterine fibroids are benign growths in the uterus that affect more than 30% of women of childbearing age. Symptomatic women suffer from extensive and prolonged menstrual bleeding, anaemia, pain, pressure and often infertility. Existing treatment options include hysterectomy, myomectomy and uterine artery embolization that are invasive and minimally invasive, involving hospitalization and several weeks of recovery time. ExAblate is an outpatient procedure and patients return home the same day and to work within one to two days.
What are Uterine Fibroids?
Uterine fibroids are benign tumors that may grow in various regions of the uterus.
The average menstruator will use over 11,000 tampons or sanitary pads in their lifetime. Vaginal and vulvar tissue that touch pads and tampons is highly permeable.
Clocking up 6 or more hours of sedentary leisure time every day may double a woman's risk of uterine fibroids before she's gone through the menopause, suggests research published in the open access journal BMJ Open.
Tonjanic Hill was overjoyed in 2017 when she learned she was 14 weeks pregnant. Despite a history of uterine fibroids, she never lost faith that she would someday have a child.
In a pre-clinical, proof-of-concept study from Johns Hopkins Medicine, researchers found that epigallocatechin gallate (EGCG), a green tea compound with powerful antioxidant properties, could be promising for both treating and preventing uterine fibroids.
A collaboration among Dr. Frank Greenway of Pennington Biomedical Research Center, Dr. Beverly Ogden of Woman's Hospital in partnership with LSU, and the University of Louisiana at Lafayette, was named as one of three award recipients at the Baton Rouge Health-Tech Catalyst Pitch Night.
Review examines the presence of estrogens and progesterone in human milk and their potential impact on infant growth and health. It explores factors influencing hormone levels and provides insights for effective intervention strategies.
In a recent study published in the journal Nutrients, researchers at Johns Hopkins Medicine reviewed the beneficial properties of green tea in alleviating symptoms of benign gynecological disorders.
Rebecca Schneyer, MD, has received the Medstar National Center for Advanced Pelvic Surgery Diversity and Inclusion Award given by the Foundation of the AAGL.
As the University of California's health system renews contracts with hundreds of outside hospitals and clinics — many with religious affiliations — some of its doctors and faculty want stronger language to ensure that physicians can perform the treatments they deem appropriate, including abortions for women or hysterectomies for transgender patients.
The Focused Ultrasound Foundation and the Children's Tumor Foundation (CTF) have established a partnership to advance innovative, noninvasive treatments in pediatrics.
When assessing new examination and treatment methods involving high-risk medical devices in accordance with §137h of the German Social Code, Book V (SGB V), the Institute for Quality and Efficiency in Health Care (IQWiG) examines the data submitted by the hospital and the manufacturer.
News-Medical talks to Dr. Marlena Fejzo about a breakthrough in the understanding of hyperemesis gravidarum, and how it could improve maternal health around the world.
Seeking to expand access to quality gynecologic care in Brooklyn, NYU Langone Health has appointed Hye-Chun Hur, MD, MPH, a prominent minimally invasive gynecologic surgeon, as director of gynecology services at NYU Langone Hospital—Brooklyn and vice chair for faculty development in the Department of Obstetrics and Gynecology at NYU Grossman School of Medicine.
In this interview, we speak to Cynthia Bailey and Dr. Yan Katsnelson about the importance of spreading awareness surrounding fibroids.
Black women who frequently experience racism before age 20 are at higher risk of reporting depressive symptoms in adulthood than those who had fewer experiences of racism in early life, according to a study by the University of North Carolina Gillings School of Global Public Health.
Obesity is associated with an increased risk of developing female reproductive disorders, however, the roles and mechanisms of obesity in the cause(s) of reproductive conditions are unclear.
A new study investigates the relationship between COVID-19 vaccination and menstrual cycle disturbances.
A new study reports on the incidence of changes in menstruation in women who have received the COVID-19 vaccine.
Fibroid symptoms, such as heavy menstrual bleeding and abdominal pain, are increasingly driving women to the emergency room.
A large survey of women in California shows significant racial and ethnic differences in the types of personal care products women use on a daily basis.